Reference:

Boehringer Ingelheim

  • Country: Germany
  • Industry: Life Sciences
  • SAP Digital Business Services Portfolio: SAP Innovative Business Solutions

The introduction of counterfeit pharmaceutical products into the legitimate supply chain has become a global threat over the past years. To respond to the challenge, SAP and Boehringer Ingelheim are co-innovating to established a blockchain-based system that ensures the unique identification and verification of individual medicine packages. Such a system will enable patients and healthcare professionals to easily perform product verification while ensuring secure data management along the supply chain. Discover how SAP Leonardo can help Life Science companies provide added value to patients by uniquely identifying and verifying pharmaceuticals to mitigate the risk of counterfeit drugs and ensuring secure data management along the supply chain.

 

Back to Reference Navigator